ClinicalTrials.gov
public full text
Public Domain
Prediction of Antidepressant Response Using Pharmacogenetics and Peripheral Lymphocytic Phenotype
The purpose of this study is to determine whether pharmacogenomic study of bioamine transporters and peripheral lymphatic biomarkers(phenotype) predict antidepressant responsiveness in advance before the appearance of the drug effects until 4\~6 weeks after drug administration.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects#905146
- Neural signaling mechanisms in depression: bridging classical monoamine hypotheses, animal models, and emerging antidepressant strategies.#545
- Gut Feeling: Understanding the Mechanisms Underlying the Antidepressant Properties of Probiotics#1172989
- Do Newer Antidepressant Drugs _Really_ Have Reduced Side Effects? Examining a Random “Real World” Sample of 300+ Receivers of Medications#70869
- Ethanolamine as a potential biomarker and therapeutic target for depressive disorder#651742
Record · ID 1010192
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive